Your browser doesn't support javascript.
loading
Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet.
Dai, Yun-Kai; Fan, Hai-Na; Huang, Kai; Sun, Xin; Zhao, Zhi-Min; Liu, Cheng-Hai.
Affiliation
  • Dai YK; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Institute of Liver Diseases, Shanghai 201203, China.
  • Fan HN; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Institute of Liver Diseases, Shanghai 201203, China.
  • Huang K; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Institute of Liver Diseases, Shanghai 201203, China.
  • Sun X; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Institute of Liver Diseases, Shanghai 201203, China.
  • Zhao ZM; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Institute of Liver Diseases, Shanghai 201203, China.
  • Liu CH; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Institute of Liver Diseases, Shanghai 201203, China.
World J Hepatol ; 15(9): 1043-1059, 2023 Sep 27.
Article de En | MEDLINE | ID: mdl-37900214

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: World J Hepatol Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: World J Hepatol Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique